Blinding of clinical investigators

被引：0
|
作者：
Abratt, RP [1 ]
机构：
[1] Groote Schuur Hosp, ZA-7925 Cape Town, South Africa
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2001年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：593 / 593
页数：1
相关论文
共 50 条
  • [41] Practical aspects of randomization and blinding in randomized clinical trials
    Bridgman, S
    Dainty, K
    Kirkley, A
    Maffulli, N
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2003, 19 (09): : 1000 - 1006
  • [42] PUBLICATION OF CLINICAL-TRIAL RESULTS - A CLINICAL INVESTIGATORS VIEW
    SLEIGHT, P
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1995, 88 : 17 - 19
  • [43] Blinding controlled-release tablets for clinical trials
    Felton, LA
    Wiley, CJ
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (01) : 9 - 18
  • [44] Blinding in pharmaceutical clinical trials: An overview of points to consider
    Crisp, Adam
    CONTEMPORARY CLINICAL TRIALS, 2015, 43 : 155 - 163
  • [45] Assessing blinding methodology in multiple sclerosis clinical trials
    Scalfari, A.
    MULTIPLE SCLEROSIS, 2006, 12 : S92 - S92
  • [46] Clinical investigators as critical determinants in pharmaceutical innovation
    Flowers, CR
    Melmon, KL
    NATURE MEDICINE, 1997, 3 (02) : 136 - 143
  • [47] Research on Core Competency Elements of Clinical Investigators
    Wang, Xin
    Zhao, Shuang
    Yang, Han
    Miao, Miao
    An, Siwei
    Yao, Wenbing
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2025, 59 (01) : 45 - 53
  • [48] Clinical investigators as critical determinants in pharmaceutical innovation
    Christopher R. Flowers
    Kenneth L. Melmon
    Nature Medicine, 1997, 3 : 136 - 143
  • [49] Declaration of the financial interests of clinical trial investigators
    Dal-Ré, R
    MEDICINA CLINICA, 1999, 113 (19): : 743 - 745
  • [50] Cancer Clinical Investigators Should Converge with Pharmacometricians
    Maitland, Michael L.
    O'Cearbhaill, Roisin E.
    Gobburu, Jogarao
    CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5182 - 5184
12345